Dahu Health Industry Co., Ltd. (SHA:600257)
China · Delayed Price · Currency is CNY 5.61
+0.10 (1.81%)
Aug 25, 2026, 11:29 AM CST
Dahu Health Industry Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 914.14 | 905.3 | 1,031 | 1,180 | 1,085 | 1,285 |
Other Revenue | 14.33 | 14.74 | 13.35 | 13.18 | 9.47 | 7.79 |
| 928.47 | 920.04 | 1,044 | 1,193 | 1,095 | 1,292 | |
Revenue Growth | -4.57% | -11.92% | -12.48% | 9.02% | -15.29% | 37.99% |
Cost of Revenue | 656.87 | 669.67 | 808.85 | 908.8 | 840.03 | 988.81 |
Gross Profit | 271.6 | 250.37 | 235.65 | 284.66 | 254.68 | 303.5 |
Selling, General & Admin | 151.45 | 154.52 | 162.84 | 188.65 | 190.58 | 240.83 |
Research & Development | 1.44 | 0.75 | 0.59 | 0.96 | 0.95 | 0.36 |
Other Operating Expenses | 19.94 | 19.3 | 16.43 | 29.75 | 27.74 | 23.75 |
Operating Expenses | 174.36 | 172.46 | 186.27 | 225.64 | 237.28 | 267.36 |
Operating Income | 97.25 | 77.91 | 49.39 | 59.02 | 17.41 | 36.14 |
Interest Expense | -31.19 | -33.67 | -36.9 | -41.62 | -43.81 | -42.05 |
Interest & Investment Income | 1.31 | 1.59 | 1.54 | 1.66 | 3.22 | 7.33 |
Other Non Operating Income (Expenses) | 3.46 | 3.66 | -8.11 | -1.88 | -2.76 | -3.51 |
EBT Excluding Unusual Items | 70.82 | 49.49 | 5.9 | 17.17 | -25.94 | -2.09 |
Impairment of Goodwill | - | - | -19.78 | - | -33.9 | - |
Gain (Loss) on Sale of Investments | 12.4 | 7.08 | -3.72 | -2.65 | -6.97 | 0.88 |
Gain (Loss) on Sale of Assets | -0.93 | -0.3 | 1.39 | 5.91 | -0.75 | 2.41 |
Asset Writedown | -1.49 | -1.49 | -6.99 | -4.12 | -2.21 | -192.38 |
Other Unusual Items | 8.11 | 5.98 | - | 11.66 | 11.57 | 8.79 |
Pretax Income | 88.91 | 60.76 | -23.19 | 27.98 | -58.21 | -182.38 |
Income Tax Expense | 30.72 | 27.44 | 37.7 | 15.78 | 15.88 | 15.16 |
Earnings From Continuing Operations | 58.19 | 33.33 | -60.89 | 12.2 | -74.09 | -197.54 |
Minority Interest in Earnings | -33.67 | -28.26 | -16.06 | -20.36 | 2.6 | 17.42 |
Net Income | 24.52 | 5.07 | -76.95 | -8.16 | -71.5 | -180.12 |
Net Income to Common | 24.52 | 5.07 | -76.95 | -8.16 | -71.5 | -180.12 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 504 | 507 | 481 | 408 | 477 | 487 |
Shares Outstanding (Diluted) | 504 | 507 | 481 | 408 | 477 | 487 |
Shares Change | 4.52% | 5.32% | 17.90% | -14.41% | -2.09% | 1.53% |
EPS (Basic) | 0.05 | 0.01 | -0.16 | -0.02 | -0.15 | -0.37 |
EPS (Diluted) | 0.05 | 0.01 | -0.16 | -0.02 | -0.15 | -0.37 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 145.17 | 208.28 | 46.12 | 142.89 | 36.05 | 16.73 |
Free Cash Flow Per Share | 0.29 | 0.41 | 0.10 | 0.35 | 0.08 | 0.03 |
Gross Margin | 29.25% | 27.21% | 22.56% | 23.85% | 23.27% | 23.48% |
Operating Margin | 10.47% | 8.47% | 4.73% | 4.95% | 1.59% | 2.80% |
Profit Margin | 2.64% | 0.55% | -7.37% | -0.68% | -6.53% | -13.94% |
Free Cash Flow Margin | 15.63% | 22.64% | 4.42% | 11.97% | 3.29% | 1.29% |
EBITDA | 116.42 | 97.77 | 71.17 | 83.11 | 42.19 | 65.49 |
EBITDA Margin | 12.54% | 10.63% | 6.81% | 6.96% | 3.85% | 5.07% |
D&A For EBITDA | 19.18 | 19.86 | 21.79 | 24.09 | 24.78 | 29.35 |
EBIT | 97.25 | 77.91 | 49.39 | 59.02 | 17.41 | 36.14 |
EBIT Margin | 10.47% | 8.47% | 4.73% | 4.95% | 1.59% | 2.80% |
Effective Tax Rate | 34.55% | 45.15% | - | 56.41% | - | - |
Revenue as Reported | 928.47 | 920.04 | 1,044 | 1,193 | 1,095 | 1,292 |
Advertising Expenses | - | 2.28 | 3 | 1.55 | 2.48 | 6.02 |